⌘K

Login Start Free

Home/Filings/4/0001493152-19-008425

4//SEC Filing

Yeaton Howard 4

Accession 0001493152-19-008425

CIK 0001321834other

View on SEC.gov Company Profile

Filed

May 29, 8:00 PM ET

Accepted

May 30, 4:05 PM ET

Size

4.4 KB

Accession

0001493152-19-008425

Insider Transaction Report

Form 4

Period: 2019-05-24

Akers Biosciences, Inc.AKER

CEO, CFO

Transactions

Award
Common Stock
2019-05-24$0.65/sh+7,500$4,875→ 30,000 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Akers Biosciences, Inc.

CIK 0001321834

Entity typeother

Related Parties

1

filerCIK 0001341910

Filing Metadata

Form type: 4
Filed: May 29, 8:00 PM ET
Accepted: May 30, 4:05 PM ET
Size: 4.4 KB

View on SEC.gov